Premium
NIH undertakes public‐private opioid initiative
Publication year - 2017
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30227
Subject(s) - general partnership , chronic pain , opioid , opioid abuse , opioid use disorder , medicine , opioid overdose , public health , substance abuse , opioid epidemic , political science , psychiatry , public administration , nursing , (+) naloxone , receptor , law
The National Institute on Drug Abuse (NIDA), under the leadership of Francis S. Collins, M.D., Ph.D., director of the National Institute of Health (NIH), is moving forward to establish a public‐private partnership addressing three major areas: (1) new and innovative medications to treat opioid use disorders and for overdose prevention and reversal; (2) safe, effective and nonaddictive strategies to manage chronic pain; and (3) neurobiology of chronic pain.